Zepbound (tirzepatide) Zepbound contains the same active ingredient as Mounjaro, comes in the same dosage strengths, and is administered via a weekly injection
Products like Trulicity and Victoza have established themselves as essential therapies in endocrinology protocols, often replacing older medications like sulfonylureas
#ORN2025 #FentanylResearch #OpioidUseDisorder #AddictionScience #PublicHealth #Research #AddictionMedicine #BehavioralHealth #NAVandAssociates #SAMHSA To view or add a comment, sign in If you ever wonder why I work at the Center for Dissemination & Implementation At Stanford (C-DIAS), this article details why
Clinicians might consider preferring GLP-1 receptor agonists over other diabetes treatments, such as insulin, for patients at high risk of obesity-associated cancers. Wang and colleagues conducted a retrospective cohort study of deidentified electronic health records on the TriNetX platform
Learn more: Lilly Medical Globals Post New Results from ATTAIN-1 An Oral Small Molecule GLP-1 Receptor Agonist for Obesity Treatment
Most specialists recommend a 2-3 month washout period